310 related articles for article (PubMed ID: 21722750)
1. The role of 20-HETE in androgen-mediated hypertension.
Wu CC; Schwartzman ML
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):45-53. PubMed ID: 21722750
[TBL] [Abstract][Full Text] [Related]
2. 20-HETE and blood pressure regulation: clinical implications.
Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
[TBL] [Abstract][Full Text] [Related]
3. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
[TBL] [Abstract][Full Text] [Related]
4. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
Wu CC; Mei S; Cheng J; Ding Y; Weidenhammer A; Garcia V; Zhang F; Gotlinger K; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
J Am Soc Nephrol; 2013 Jul; 24(8):1288-96. PubMed ID: 23641057
[TBL] [Abstract][Full Text] [Related]
5. Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.
Lukaszewicz KM; Lombard JH
Clin Sci (Lond); 2013 Jun; 124(12):695-700. PubMed ID: 23438293
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats.
Jíchová Š; Doleželová Š; Kopkan L; Kompanowska-Jezierska E; Sadowski J; Červenka L
Am J Med Sci; 2016 Dec; 352(6):618-630. PubMed ID: 27916218
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.
Wu CC; Cheng J; Zhang FF; Gotlinger KH; Kelkar M; Zhang Y; Jat JL; Falck JR; Schwartzman ML
Hypertension; 2011 Apr; 57(4):788-94. PubMed ID: 21321301
[TBL] [Abstract][Full Text] [Related]
8. 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.
Savas Ü; Wei S; Hsu MH; Falck JR; Guengerich FP; Capdevila JH; Johnson EF
J Biol Chem; 2016 Aug; 291(32):16904-19. PubMed ID: 27298316
[TBL] [Abstract][Full Text] [Related]
9. Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.
Singh H; Schwartzman ML
Pharmacol Rep; 2008; 60(1):29-37. PubMed ID: 18276983
[TBL] [Abstract][Full Text] [Related]
10. Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid.
Moreno C; Maier KG; Hoagland KM; Yu M; Roman RJ
Am J Hypertens; 2001 Jun; 14(6 Pt 2):90S-97S. PubMed ID: 11411771
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat.
Schwartzman ML; da Silva JL; Lin F; Nishimura M; Abraham NG
Nephron; 1996; 73(4):652-63. PubMed ID: 8856265
[TBL] [Abstract][Full Text] [Related]
12. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Sodhi K; Wu CC; Cheng J; Gotlinger K; Inoue K; Goli M; Falck JR; Abraham NG; Schwartzman ML
Hypertension; 2010 Nov; 56(5):871-8. PubMed ID: 20837888
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
Imig JD
Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hypertension: role of 20-HETE.
Yanes LL; Lima R; Moulana M; Romero DG; Yuan K; Ryan MJ; Baker R; Zhang H; Fan F; Davis DD; Roman RJ; Reckelhoff JF
Am J Physiol Regul Integr Comp Physiol; 2011 Jun; 300(6):R1543-8. PubMed ID: 21474427
[TBL] [Abstract][Full Text] [Related]
15. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
16. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
17. Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.
Soler A; Hunter I; Joseph G; Hutcheson R; Hutcheson B; Yang J; Zhang FF; Joshi SR; Bradford C; Gotlinger KH; Maniyar R; Falck JR; Proctor S; Schwartzman ML; Gupte SA; Rocic P
J Mol Cell Cardiol; 2018 Apr; 117():88-99. PubMed ID: 29428638
[TBL] [Abstract][Full Text] [Related]
18. The CYP/20-HETE/GPR75 axis in hypertension.
Froogh G; Garcia V; Laniado Schwartzman M
Adv Pharmacol; 2022; 94():1-25. PubMed ID: 35659370
[TBL] [Abstract][Full Text] [Related]
19. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
Cheng J; Garcia V; Ding Y; Wu CC; Thakar K; Falck JR; Ramu E; Schwartzman ML
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1917-24. PubMed ID: 22723444
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Garcia V; Joseph G; Shkolnik B; Ding Y; Zhang FF; Gotlinger K; Falck JR; Dakarapu R; Capdevila JH; Bernstein KE; Schwartzman ML
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(1):R71-8. PubMed ID: 25924878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
